Randy Steven Laxer

Partner

Tokyo, 81 3 3214 6522

Download vCard

Education

Michigan State University (B.A., 1994)
;
University of Michigan Law School (J.D., 1998)

Practices

Mergers + Acquisitions | Japan

Joint Ventures + Global Strategic Alliances | Japan

Emerging Companies + Venture Capital

Bar Admissions

New York
Japan (Gaikokuho-Jimu-Bengoshi)

Randy Laxer serves as the co-chair of the firm's Global Corporate Department. His practice focuses on cross-border mergers and acquisitions, private equity and venture capital, strategic alliances and joint ventures. His experience in this area includes numerous inbound and outbound buyouts, complex international joint ventures and strategic and venture capital investments in high-tech, life sciences and media industries.

Mr. Laxer is highly recommended by The Legal 500 Asia Pacific 2013 edition and International Financial Law Review 2011 edition for his M&A and corporate law expertise. He is also the only foreign lawyer to be endorsed in the 2011/12 edition of Practical Law Company's Venture Capital multi-jurisdictional guide.

Prior to joining Morrison & Foerster, Mr. Laxer worked for O'Melveny & Myers LLP. In addition to Tokyo, Mr. Laxer also has practiced in Silicon Valley and New York.

Mr. Laxer attended Konan University in Kobe, Japan and Stanford University’s Inter-University Center for Japanese Studies in Yokohama, Japan. He is fluent in Japanese.

ON Semiconductor's $600 million acquisition of Sanyo Semiconductor.

Represented ON Semiconductor in its $600 million acquisition of Sanyo Semiconductor, the first ever acquisition of a major Japanese semiconductor company by a US company (and one of the largest inbound investments into Japan to date). Recipient of “M&A Deal of the Year” by The M&A Advisor's International M&A Awards.

Taisho's $310 million acquisition of Bristol-Myers Squibb's Asia Pacific OTC business

Represented Taisho Pharmaceutical in its acquisition of Bristol-Myers Squibb's Indonesia manufacturing and distribution subsidiary as well as brand rights for over-the-counter pharmaceutical products sold throughout Asia.

SoftBank’s $200 million investment in InMobi.

Represented SoftBank in its $200 million investment in InMobi Pte. Ltd., a mobile advertising and payment technology company based in Bangalore, India.

Ajinomoto’s $175 million acquisition of Althea Technologies.

Represented Ajinomoto in its $175 million acquisition of Althea Technologies, a leading U.S.-based biopharmaceutical contract development and manufacturing organization.

Sumitomo’s acquisition of Sunstate Equipment.

Represented Sumitomo in its acquisition of a controlling interest in Sunstate Equipment, a leading US-based construction equipment rental company.

Avnet’s tender offer for Internix.

Represented Avnet in its tender offer for all outstanding shares of Internix, an electronic components distributor listed on the Tokyo Stock Exchange.

Asahi Kasei’s acquisition of Crystal IS.

Represented Asahi Kasei in its acquisition of Crystal IS, a leading US-based developer of ultraviolet light emitting diodes (UVC LEDs).

Ricoh/IKON Office Solutions

Represented Ricoh Company, Ltd., Japan's second-largest maker of office machines, in its $1.6 billion acquisition of IKON Office Solutions, Inc., the world's largest independent channel for document management systems. (2008)

JAL's negotiations with American Airlines and Delta.

Represented Japan Airlines in its negotiation of its proposed strategic and capital alliance with Delta and American Airlines as part of JAL's ongoing restructuring.

SRI Sports $130-million acquisition of Cleveland Golf

Represented SRI Sports' in its $130 million acquisition of Cleveland Golf, a California-based maker of high performance golf equipment, from Quiksilver.